Statement on “Opill”
Jul 14, 2023
“With the F.D.A.’s approval of the nation’s first over-the-counter birth control pill, we are one step closer to improving access to contraception for New Yorkers,” said NYC Health + Hospitals Chief Women’s Health Officer Wendy Wilcox, MD, MPH, MBA, FACOG. “This is a win for reproductive health in the face of increasing restrictions to reproductive rights. We hope that Opill will truly be accessible by being available and affordable. At NYC Health + Hospitals, we will continue to offer the complete spectrum of reproductive health services, fighting to maintain access to essential reproductive health care for New Yorkers.”